Fusion Pharmaceuticals



Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors.

John Crowley
Chief Financial Officer
Eric Burak
Chief Scientific Officer
James O'Leary
Chief Medical Officer
Maria Stahl
Chief Legal Officer
Cara Ferreira
Chief of Staff
Isabelle Dussault
SVP, Research
Victor Paulus
SVP, Regulatory Affairs

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.